Citius Pharmaceuticals Inc (CTXR) — Defensive Interval Ratio

Latest as of March 2026: 7 days

Citius Pharmaceuticals Inc (CTXR) has a Defensive Interval Ratio of 7 days as of March 2026. Defensive assets of $1.08 Million (cash $-, short-term investments $-, receivables $1.08 Million) cover 7 days of daily cash needs of $150.73K/day. See CTXR working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

7 days
Days of operational coverage

Defensive Assets

$1.08 Million
Cash + ST Investments + Receivables

Daily Cash Need

$150.73K
Current Liabilities ÷ 365

Current Liabilities

$55.02 Million
USD

Citius Pharmaceuticals Inc Defensive Interval Ratio (2014–2018)

This chart shows how Citius Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 2 annual periods from 2014 to 2018. As of March 2026, the ratio stands at 7 days, meaning defensive assets of $1.08 Million can fund 7 days of operations without new revenue. See net asset quality index of Citius Pharmaceuticals Inc to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Citius Pharmaceuticals Inc (2014–2018)

The table below presents the year-by-year Defensive Interval Ratio for Citius Pharmaceuticals Inc from 2014 to 2018, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Citius Pharmaceuticals Inc market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2018 94 days $818.34K $8.73K/day $- $- ▲ +94 days
2014 0 days $0.00 $6.30K/day $- $0.00
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)